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Abstract     
Introduction. Aortoenteric fistulas constitute a rare, but severe clinical problem involving a pathological 
connection between the abdominal aorta and gastrointestinal tract. We distinguish primary and, much more 
frequent, secondary fistulas. All such fistulas require urgent surgical treatment. Currently, the most common 
treatment method involves open in situ prosthesis replacement or an extra-anatomical by-pass. Endovascular 
procedures offer an alternative to open surgery, but remain controversial.
Material and methods. The analysis included 6 surgical procedures in 5 patients with aorto-duodenal fistula 
treated at the Department of Surgery of the 4. Military Clinical Hospital over the years 2010–2016. Open 
surgery was performed in 4 cases, while 2 patients underwent stentgraft implantation. Diagnostics consisted of 
an angio-CT and upper gastrointestinal tract endoscopy. All patients were diagnosed with radiological signs of 
prosthesis infection, 2 of 6 patients died during the perioperative period. Surgical complications were observed 
in 5 of 6 cases (83%). 
Results. Endovascular treatment was associated with a reduction in the number of early postoperative com-
plications and shortening of hospital stay.
Conclusions. Based on the results and literature data, stentgraft implantation into the aorto-duodenal fistula 
appears to be a viable alternative treatment method. 
Key words: stentgraft, aorto-duodenal fistula, aortic prosthesis, abdominal aorta,  
gastrointestinal hemorrhage
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Introduction
Aortoenteric fistula is a rare condition that involves 
a pathological connection between the aorta and the 
gastrointestinal tract. In about 80% of cases, fistulas 
are formed between the third and fourth section of 
the duodenum and the adjacent abdominal aorta. In 
15% of cases, the connection develops between aorta 
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and small intestine [1–4], and in 5% between aorta 
and large intestine. We may distinguish primary aor-
toenteric fistulas (PAEF) and secondary aortoenteric 
fistulas (SAEF).
PAEF is a rare complication associated mainly with 
an abdominal aortic aneurysm and advanced athero-
sclerosis. PAEF is identified in 0.04–0.07% of autop-
sies [5]. Typical symptoms include gastrointestinal 
bleeding, pulsatile abdominal mass and abdominal pain. 
SAEF is more common than PAEF, with its inci-
dence reaching 0.77–1.6% in patients after prosthesis 
implantation due to abdominal aortic aneurysm. It 
is thought that the main cause of fistula formation 
involves mechanical irritation of the posterior wall of 
duodenum by a layer of sutures in the upper anasto-
mosis of the prosthesis and subsequent inflammatory 
process in the adjacent tissues [1, 5–7]. SAEF may be 
suspected in patients after abdominal aortic aneurysm 
surgery presenting with recurrent gastrointestinal 
bleeding and signs of systemic infection [1, 2, 6, 7]. 
Untreated aortoenteric fistulas are associated 
with 100% mortality. Quick diagnosis and appropri-
ate treatment give the patient a chance to survive, 
although treatment is associated with a high risk 
of complications and perioperative death, reaching 
19–77% depending on the surgical method [6, 8, 9]. 
To date, open surgery has played a major role in the 
treatment of aortoenteric fistulas, although endovas-
cular treatment is being used in an increasing number 
of patients. 
Material and methods
Five patients with aortoenteric fistulas have been 
admitted and treated at the Department of Surgery 
of the 4. Military Clinical Hospital over the years 
2010–2016. One patient underwent surgery twice 
due to recurrence of the aortoenteric fistula. All cases 
involved secondary fistulas in patients who had under-
gone prosthesis implantation due to abdominal aortic 
aneurysm. All fistulas developed between abdominal 
aorta and the 3rd or 4th section of the duodenum. All 
patients were male, aged 59–73 years (mean age 66.8 
years). The time between implantation of the vascular 
prosthesis and the occurrence of symptoms ranged 
from 5 months to 9 years (mean 41.8 months). Patients 
were acutely admitted to hospital and every one un-
derwent computed angiotomography. Gastroscopy was 
performed in 5 cases. In total, 6 repair surgeries were 
performed: 4 primary in situ prosthesis replacement 
procedures (silver-coated prosthesis) with primary 
duodenal closure, and 2 stentgraft implantations. In 
one case, endovascular prosthesis implantation was 
accompanied by the application of retroperitoneal 
drainage and microjejunostomy formation with gastric 
drainage using Taylor’s method. 
Results
All patients were acutely admitted to the Depart-
ment. Upper gastrointestinal bleeding (5 of 6 patients — 
83%) was the most frequent complaint that prompted 
hospital admission. Fever > 38oC was present in 4 cases 
(66%) and 2 patients reported abdominal pain (33%). 
Laboratory findings included leukocytosis ranging from 
13.5 × 103/mm3 to 31.7 × 103/mm3 (mean 15.4 × 
103/mm3) and elevated C-reactive protein (CRP) level 
ranging from 43 mg/L to 139 mg/L (mean 61 mg/L). 
Infection of endovascular prosthesis was described 
in all angio-CT studies, although fistula was visualized 
in only 4 patients (66%). The dominating radiological 
symptoms included widening of periaortic tissues due 
to inflammation (100%), inflammatory infiltration of the 
duodenum (4 cases, 66%), and presence of periaortic 
gas bubbles (3 patients, 50%). 
Endoscopy was performed in all patients with 
symptoms of gastrointestinal bleeding. The source of 
bleeding was found in 2 cases (40%), but attempts at 
stopping the hemorrhage failed. In one patient exam-
ination revealed a thrombus at the site of the fistula 
without active bleeding. 
Following the examinations and diagnosis of SAEF, 
all patients were referred for urgent surgery. In four 
cases the infected vascular prosthesis was removed 
and replaced with a silver-coated prosthesis. In all 
cases, duodenal repair was performed during the 
same surgery.
Two patients who had been treated with classic 
open surgery died: one patient due to massive intra-
operative hemorrhage and the second patient because 
of multiorgan failure in the course of systemic infection 
34 days after surgery. Infection of the surgical wound 
was noted in two patients and one patient was reoper-
ated due to acute ischemia of the right leg. In one case 
recurrence of aorto-duodenal fistula was diagnosed, 
accompanied by massive hemorrhage and retroperito-
neal abscess. Mean hospitalization time among patients 
treated with open surgery amounted to 37 days. One 
patient was considered fully recovered after a 24-month 
follow-up period.
Microbiological examination of material obtained 
from the area of aorto-duodenal fistula revealed G(+) 
bacteria, i.e. Staphylococcus aureus MRSA in 2 patients 
and Staphylococcus epidermidis in another 2 cases. Blood 
cultures demonstrated systemic infection in all patients 
infected with the above pathogens. Prolonged antibiotic 
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In 71% of cases, SAEF is secondary to implantation 
of aortic prosthesis due to the abdominal aortic aneu-
rysm and in 38% after implantation of aortobifemoral 
prosthesis in the course of Leriche syndrome [8, 10]. 
The exact pathogenesis of fistula formation has not been 
entirely elucidated, although more frequent occurrence 
of fistulas following surgical repair of aortic aneurysm 
implies an association with earlier weakening of duode-
nal wall and greater aortic diameter [1, 11, 12]. Typical 
symptoms demonstrated by patients with SAEF include 
coffee-ground vomit and melena. They are observed 
in 60–76% of cases and constitute the most common 
symptom [1–3, 8, 10, 13]. In our material gastroin-
testinal bleeding was observed in 5 of 6 cases (83%). 
However, bleeding site or thrombus was identified in 
only 3 patients (50%). Visualization of the source of 
bleeding may be impaired, as fistulas are usually located 
in the 3rd and 4th section of the duodenum; thus, it is only 
successful in 40–76% of cases [14–16]. Gastrointestinal 
hemorrhage is often accompanied by general symptoms 
of infection (fever, leukocytosis, elevated CRP), which 
are present in 30–87% of cases [1, 14, 17, 18]. In the 
presented material 3 of 6 patients (50%) presented with 
symptoms of sepsis and 2 of 6 patients (33%) reported 
abdominal pain. Less frequent symptoms accompany-
ing SAEF include pulsatile abdominal mass, lower limb 
ischemia, prosthesis occlusion, and back pain [14, 19]. 
Computed angiotomography is the primary and 
the most reliable diagnostic modality. Its sensitivity is 
estimated at 94% and specificity reaches 85% [14, 20, 
21]. In our material, inflammation of the periaortic space 
associated with prosthesis infection was identified in all 
patients. However, direct visualization of aorto-duo-
denal fistula was only possible in 4 of 6 studies (66%). 
Ultrasonography and angiography may play an adjuvant 
role in the diagnosis of SAEF [8, 19]. Untreated SAEF 
is associated with almost 100% mortality and for that 
reason, surgical intervention should be implemented as 
quickly as possible [4]. Urgent treatment is associated 
with 60% mortality, decreasing to 38% if the patient 
may be prepared for the procedure [14]. Current thera-
peutic options include open surgery (OS) or endovas-
cular procedure (EVAR). Open surgery usually involves 
therapy with vancomycin was applied according to the 
antibiogram. A G-negative Pseudomonas aeruginosa was 
identified in 1 patient who died during surgery. 
Two patients were treated with endovascular stent-
graft implantation (EVAR) technique. In one case the 
procedure was performed in a patient with recurrent 
aorto-duodenal fistula and massive gastrointestinal 
bleeding. Additionally, angio-CT study revealed a ret-
roperitoneal abscess. On the second day after surgery, 
following stabilization of patient’s general condition, 
microjejunostomy was performed and retroperitoneal 
drainage was maintained for 14 days. At the same time, 
gastric drainage using Taylor’s method was applied in 
order to decompress the gastrointestinal tract. In the 
second case, the procedure consisted of stentgraft 
implantation followed by therapy with intravenous 
and oral antibiotics. Patient treated with EVAR due to 
recurrent fistula required reoperation due to pseu-
doaneurysm in the area of inferior anastomosis of 
aortobifemoral prosthesis. Serial angio-CT studies 
performed 6, 12, and 18 months after the procedure 
did not reveal inflammatory lesions in the periaortic 
space. The second patient was readmitted to hospital 
8 months later due to fever and leukocytosis. Comput-
ed angiotomography showed persistent inflammatory 
changes in the periaortic region. Follow-up examina-
tion performed after implementation of intravenous 
antimicrobial agents and 6 months of oral antibiotics 
demonstrated regression of inflammatory lesions, the 
absence of systemic symptoms and normalization of 
leukocyte levels. Mean hospitalization time among 
patients treated with EVAR amounted to 29 days. 
Discussion
Aortoenteric fistulas are rare, late complications 
of aortic prosthesis implantation. The third and fourth 
section of the duodenum is the most frequent site of 
fistula formation (80%), followed by small intestine 
(15%) and colon (5%) [1–4, 9, 11]. 
Table 1. Patients undergoing surgery due to secondary  
aortoenteric fistulas 
Patient Age Time from surgery 
(months)
1 62 28
2 59 61
3 71 36
4 73 11
5 69 110
5* 69 5
*Patient 5 was reoperated due to fistula recurrence
Table 2. Comparison of complication rates for open surgery/ 
/endovascular aortic repair (OS/EVAR) in our material
Complication OS EVAR
Death 2 –
Wound infection 2 1
Acute limb ischemia 1 –
Sepsis 1 1
Recurrent fistula 1 –
Periaortic abscess 1 –
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removal of the infected aortic prosthesis and replacing 
it with silver-coated prosthesis [1, 4, 8, 11, 14]. Alter-
natively, rifampicin-soaked prosthesis, homograft, or 
patient’s own vein may be used [6, 10]. Extra-anatomi-
cal axillofemoral bypass is another treatment option 
[1, 10, 14, 18]. Open surgery is associated with a very 
high risk of complications. Thirty-day mortality after 
the procedure reaches 30–56% [1, 8, 11, 14]. Postop-
erative complications occur in up to 77% of patients 
treated with an open method [11, 14, 20]. In the pre-
sented material 5 procedures were performed urgently 
and one after prior preparation. Mortality reached 50% 
(2 of 4 patients). One death was associated with massive 
intraoperative hemorrhage, the other with multiorgan 
failure in the course of septic shock. Complications 
occurred in 2 of 3 (66%) operated subjects who sur-
vived the surgery. 
Endovascular treatment involves implantation 
of a stentgraft to cover the fistula. EVAR may be 
used as ad hoc or definitive treatment. In the first 
case, the aim of stentgraft implantation is to control 
bleeding and stabilize the patient’s condition. Subse-
quently, after preparing the patient for surgery and 
implementing long-term antibiotic therapy, open in 
situ prosthesis implantation or axilofemoral bypass 
grafting is performed [1, 6, 11, 14]. The time period 
between EVAR and OS ranges from 300 to 567 days 
[6, 11]. In the case of definitive treatment, stent-
graft implantation is the final procedure. Comparing 
EVAR to OS one may note significant reduction in 
rates of early mortality (0% vs. 35%) and other 
complications (25% vs. 77%) [14, 20]. Meantime of 
hospital stay is also shortened — 19.4 vs. 44 days 
[21]. However, EVAR is associated with significantly 
greater risk of sepsis. During the two years after the 
procedure, the risk of sepsis after EVAR amounts 
to 42%, while for OS it is 19% [1, 11]. The risk of 
developing sepsis after EVAR during the first two years 
may be achieved through the application of antibiotic 
therapy for a period of at least 6 months. With one 
antibiotic the risk amounts to 63%, in the absence of 
antibiotic therapy — 100% [1, 11, 20]. Lifelong use of 
a single antibiotic should be considered after EVAR [11]. 
There were no deaths after EVAR in our material. 
One patient developed an inguinal pseudoaneurysm 
that required repeat surgery. One patient required 
hospitalization 8 months after the procedure due to 
the symptoms of sepsis, which resolved after prolonged 
antibiotic therapy. One EVAR procedure, performed 
in order to control massive gastrointestinal bleeding 
in a patient with recurrent SAEF, required laparotomy 
due to the presence of a periaortic abscess. 
Conclusions 
SAEF is a rare, severe complication of aortic pros-
thesis implantation. It usually involves the 3rd and 4th 
section of the duodenum. 
Treatment of SAEF is associated with high perioper-
ative mortality and high risk of complications. 
Each patient after gastrointestinal hemorrhage 
with a history of aortic prosthesis implantation should 
undergo diagnostics toward SAEF. 
EVAR remains controversial as a treatment option 
for SAEF due to the fact that stentgraft is implanted into 
an infected region. However, it significantly reduces 
mortality and complication rates. 
EVAR may be used both as an ad hoc life-saving 
procedure supplemented by delayed open surgery, as 
well as a definitive treatment option. 
Long-term antibiotic therapy in order to reduce the 
risk of sepsis as a late complication plays an important 
role in all patients treated for SAEF. 
Open surgery seems to be the method of choice 
for patients who may be prepared for surgery and with 
predicted long survival time. Endovascular procedures 
are better suited for treatment of massive hemorrhages 
and for patients in poor general condition. 
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